Full Year 2022 Roche Holding AG Earnings Call Transcript
My name is Henrik, and I'm the technical operator for today's call.
Kindly know that the webinar is being recorded. (Operator Instructions) One last remark. If you would like to follow the presented slides on your end as well, please feel free to go to roche.com/investors to download the presentation.
At this time, it's my pleasure to introduce you to Severin Schwan, CEO, Roche Group. Mr. Schwan, the stage is yours.
Thank you very much, and a warm welcome from my side. Thank you for joining us for our management brief -- our briefing on the 2022 group results. Let's get right into the numbers.
Overall, we delivered a good performance in both divisions very much driven by the newer medicines on the one hand and a strong base business in Diagnostics. This was partly offset by the starting decline of our COVID-related sales, which amounted to roughly CHF 1 billion last year. Now as far as the pipeline is concerned, on the one hand, as you know, we did have some setbacks
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
